Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial
暂无分享,去创建一个
S. Solomon | M. Pfeffer | A. Desai | J. McMurray | M. Zile | M. Packer | B. Claggett | M. Lefkowitz | L. Chiang | M. Minamisawa | Kota Suzuki
[1] A. Kirtane,et al. Long‐Term Clinical Outcomes Following Revascularization in High‐Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease , 2020, Journal of the American Heart Association.
[2] Akshay S. Desai,et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. , 2019, The New England journal of medicine.
[3] D. Atar,et al. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial , 2018, Circulation. Heart failure.
[4] Akshay S. Desai,et al. Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial , 2016, Circulation. Heart failure.
[5] Laura G. Qualls,et al. Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction. , 2012, JAMA.
[6] Zhiliang Ying,et al. Semiparametric regression for the mean and rate functions of recurrent events , 2000 .
[7] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[8] A. Pablos-Mendez,et al. Run-in periods in randomized trials: implications for the application of results in clinical practice. , 1998, JAMA.
[9] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[10] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.